AMPro

Aging and Metabolic Programming

AMPro aims at investigating three interrelated aspects that help determine metabolic health and aging in humans:

a) the identification and functional characterization of both pre- and post-natal genetic and epigenetic programming events regulating metabolism,

b) the characterization of organ cross-talk mechanisms in aging, and

c) the determination of impaired tissue repair capacities upon aging.

By combining results from all three research tracks, AMPro aims at the preventive and therapeutic resetting of metabolic programming to establish novel and unifying treatment regimens in age-related human metabolic pathologies, including type 2 diabetes, cancer, cardio-vascular, neurodegenerative and infectious diseases.

Coordinators              

Prof. Dr. Stephan Herzig
Institute for Diabetes and Cancer IDC
Helmholtz Center Munich 

Prof. Dr. Aurelio Teleman
Division Signal Transduction in Cancer and Metabolism
German Cancer Research Center DKFZ

Partners

• Helmholtz Center Munich – HMGU
• German Cancer Research Center - DKFZ
• German Center for Neurodegenerative Diseases – DZNE
• Max Delbrück Center Berlin – MDC
• Helmholtz Centre for Infection Research - HZI